By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Protalex, Inc. 



Albuquerque  New Mexico  87190  U.S.A.
Phone: 505-260-1726 Fax:


SEARCH JOBS


Industry
Biotechnology






Company News
Protalex, Inc. (PRTX) Announces Data from U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients Presented At The 2014 EULAR Annual European Congress of Rheumatology 6/13/2014 7:56:52 AM
Protalex, Inc. (PRTX) Announces Preliminary Unblinded Findings From Cohorts 1-4 Of U.S. Phase 1b Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 6/3/2014 9:34:36 AM
Protalex, Inc. (PRTX) To Present Findings From U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients At The 2014 EULAR Annual European Congress Of Rheumatology 5/15/2014 8:54:32 AM
Protalex, Inc. (PRTX) Adds Three Industry Leaders To Clinical Development Team 5/5/2014 6:55:17 AM
Protalex, Inc. (PRTX) Announces Interim Findings From U.S. Phase 1(b) Trial Of PRTX-100 In Active Rheumatoid Arthritis Patients 2/10/2014 8:10:51 AM
Protalex, Inc. (PRTX) Announces Appointment Of Marco M. Elser To Its Board Of Directors 2/5/2014 7:58:13 AM
Protalex, Inc. (PRTX) Announces Completion Of $2.8 Million Private Placement 1/23/2014 9:27:36 AM
Protalex, Inc. (PRTX) Initiates Enrollment of Final Cohort in Phase 1b Trial of PRTX-100 in Active Rheumatoid Arthritis Patients 10/31/2013 12:16:59 PM
Protalex, Inc. (PRTX) Announces Two Posters Accepted for Presentation at 2013 American College of Rheumatology Annual Meeting 9/30/2013 6:51:37 AM
Protalex, Inc. (PRTX) to Present at the Rodman & Renshaw 15th Annual Healthcare Conference 9/5/2013 8:11:45 AM
123456
//-->